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Aims Activation of transient receptor potential vanilloid type-1 (TRPV1) channels may affect lipid storage and the cellular
inflammatory response. Now, we tested the hypothesis that activation of TRPV1 channels attenuates atherosclerosis
in apolipoprotein E knockout mice (ApoE2/2) but not ApoE2/2TRPV12/2 double knockout mice on a high-fat diet.
Methods
and results
Both TRPV1 mRNA and protein expression were identified in vascular smooth muscle cells (VSMC) and in aorta
from C57BL/6J mice using RT–PCR, immunoblotting, and immunohistochemistry. In vitro, activation of TRPV1 by
the specific agonists capsaicin and resiniferatoxin dose-dependently increased cytosolic calcium and significantly
reduced the accumulation of lipids in VSMC from C57BL/6J mice but not from TRPV12/2 mice. TRPV1 activation
increased ATP-binding cassette transporter A1 (ABCA1) expression and reduced low-density lipoprotein-related
protein 1 (LRP1) expression in VSMC by calcium-dependent and calcineurin- and protein kinase A-dependent mech-
anisms. These results showed increased cellular cholesterol efflux and reduced cholesterol uptake. In vivo, long-term
activation of TRPV1 by capsaicin for 24 weeks increased ABCA1 and reduced LRP1 expression in aorta from
ApoE2/2 mice on a high-fat diet. Long-term activation of TRPV1 significantly reduced lipid storage and atherosclero-
tic lesions in the aortic sinus and in the thoracoabdominal aorta from ApoE2/2 mice but not from ApoE2/2
TRPV12/2 mice on a high-fat diet. These findings indicated that TRPV1 activation ameliorates high-fat diet-
induced atherosclerosis.
Conclusion Activation of TRPV1 may be a novel therapeutic tool to attenuate atherosclerosis caused by a high-fat diet.
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1. Introduction
Atherosclerosis is considered to be an inflammatory process consisting
largely of the accumulation of lipids within the artery wall.1,2 Vascular
smooth muscle cells (VSMC) have been demonstrated to express a
variety of cholesterol uptake receptors and reverse cholesterol trans-
porters, including low-density lipoprotein (LDL) receptor, LDL
receptor-related protein 1 (LRP1), and ATP-binding cassette transpor-
ter A1 (ABCA1).3,4 These studies suggest that lipid accumulation in
VSMC contributes to atherosclerosis development. Recent studies
showed that transient receptor potential vanilloid type-1 (TRPV1)
channels are expressed in vessels.5,6 TRPV1 channels are activated by
the specific agonist, capsaicin, the ‘hot’ component of chili peppers.7,8
Activation of TRPV1 regulates the expression of endothelial cell-
derived calcitonin gene-related peptide, which causes protective
effects on vascular endothelial cells.6 We recently showed that
chronic TRPV1 activation by dietary capsaicin increases the phosphoryl-
ation of protein kinase A (PKA) and endothelial nitric oxide (NO)
synthase (eNOSser1177) and thus the production of NO in endothelial
cells.9 Furthermore, our previous work indicated that activation of
TRPV1 by capsaicin also affects lipid metabolism and prevents obesity
in male mice.10 From these results, the hypothesis arises that activation
of TRPV1 channels may attenuate atherosclerosis. We investigated this
hypothesis in apolipoprotein E knockout mice (ApoE2/2) and ApoE/
TRPV1 double knockout mice (ApoE2/2TRPV12/2) on a high-fat
diet. In vitro, activation of TRPV1 significantly reduced the accumulation
of lipids in VSMC due to an increased cholesterol efflux and reduced
cholesterol uptake. In vivo, long-term activation of TRPV1 significantly
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reduced lipid storage and atherosclerotic lesions in the aortic sinus and
in the thoracoabdominal aorta from ApoE2/2 but not from ApoE2/2
TRPV12/2 mice on a high-fat diet. These findings indicated that
TRPV1 activation ameliorates a high-fat diet-induced atherosclerosis.
2. Methods
Methods for cellular total cholesterol analysis, PCR, transient siRNA
transfection, biochemical analyses, immunohistochemistry, evaluation of
atherosclerotic lesions, and histological analysis are available in the Sup-
plementary material online.
2.1 Genetic mouse models
The investigation conforms with the Guide for the Care and Use of Lab-
oratory Animals published by the US National Institutes of Health (NIH
Publication No. 85-23, revised 1996) and was approved by the
Experimental Animal Ethics Committee of Daping Hospital. ApoE-
deficient mice (ApoE2/2) and TRPV1-deficient mice (TRPV12/2) were
purchased from the Jackson Laboratory (Bar Harbor, ME, USA). The
ApoE2/2TRPV12/2 mice were generated by breeding TRPV12/2 mice
(on C57 BL/6 background) with ApoE2/2 mice. The resulting heterozy-
gous progeny were interbred with each other to produce homozygote
ApoE2/2TRPV12/2 mice. PCR was used to identify the ApoE genotype
and TRPV1 genotype. The expression level of TRPV1 protein was deter-
mined by western blot analysis.
To identify the ApoE genotype, the following set of primers was used: F:
5′-GCCTAGCCGAGGGAGAGCCG-3′; R(WT): 5′-TGTGACTTGGGA
GCTCTGCAGC-3′ and R(knock out): 5′-GCCGCCCCGACTGCAT
CT-3′. For genotyping TRPV1, following three primers were used: F:
5′-CACGAGACTAGTGAGACGTG-3′ ; F(WT): 5′-CCTGCTCAACAT
GCTCATTG-3′ ; R(knock out): 5′-TCCTCATGCACTTCAGGA AA-3′.
The male ApoE2/2 and ApoE2/2 TRPV12/2 mice were randomized
into four groups: one group received standard laboratory chow, one
group received a high-fat diet, one group received standard laboratory
chow plus 0.01% capsaicin (Sigma-Aldrich), and one group received a
high-fat diet plus 0.01% capsaicin for 24 weeks. The high-fat diet was sup-
plied with crude protein (18.8%), crude fat (16.2%), crude ash (5.2%),
crude fibre (3.98%), nitrogen-free extract (45.2%), calcium (1.24%), phos-
phorus (0.83%), lysine (1.38%), and methionine/cystine (0.78%) (Shanghai
Slac Laboratory Animal Co., Ltd, Shanghai, China). Food intake of all mice
was measured. Mice were anaesthetized adequately by inhalation of iso-
flurane (5% for induction; 1% for maintenance) for blood collection and
sacrificed by CO2 inhalation for isolation of the aorta. The adequacy of
anaesthesia was monitored by testing tactile stimulus response and fore-
limb or hindlimb pedal withdrawal reflex, and continual observation of
respiratory pattern, mucous membrane colour, and responsiveness to
manipulations throughout all the procedure.
2.2 Cell culture
VSMC were obtained from thoracic aorta of mice and cultured by the
tissue explant method as described.11 VSMC were maintained in Dulbec-
co’s modified Eagle’s medium supplemented with 10% foetal calf serum
(HyClone) containing 100 mg/mL penicillin and 100 mg/mL streptomycin
(GIBCO, USA). Cultured VSMC were plated and grew at 378C in a
humidified atmosphere of 95% air/5% CO2. To verify that cultured cells
were VSMC, immunocytochemical localization of smooth muscle-specific
a-actin was performed using anti-smooth muscle a-actin monoclonal anti-
body (Santa Cruz Biotechnology, USA). VSMC between Passages 2 and 6
were used. Quiescent VSMC were obtained by incubation with serum-
free medium for 12 h before all the in vitro experimental procedures
were performed.
2.3 Western blotting
Aortae were homogenized and cells were lysed in high-salt extraction
buffer (0.5 mol/L Tris, 1% NP-40, 1% Triton X-100, 1 g/L sodium
dodecyl sulfate (SDS), 1.5 mol/L NaCl, 0.2 mol/L EDTA, and 0.01 mol/L
EGTA) plus 0.2 mmol/L protease inhibitor, placed at 2208C for 20 min,
and centrifuged at 12 000 g at 48C for 20 min to remove insoluble
material. Protein concentrations were determined using a DC protein
assay kit. Twenty micrograms of lysates were separated by SDS–poly-
acrylamide gel electrophoresis, transferred to polyvinylidene difluoride
membranes, and probed with antibodies for TRPV1 (Alomone Labs,
Jerusalem, Israel), LRP1, ABCA1, GAPDH, and b-actin (Santa Cruz
Biotechnology, USA), respectively. After incubation with secondary anti-
bodies for 2 h, the proteins were detected by enhanced chemilumines-
cence and quantified using a Gel Doc 2000 Imager (Bio-Rad, CA, USA).
Each sample was processed at least three times.
2.4 Measurement of intracellular calcium
Cytosolic calcium concentration was measured in cultured VSMC using
the fluorescent dye technique as described by our group.12 VSMC
grown on glass cover slips were loaded with 2 mmol/L fura 2-AM and
0.025% Pluronic F-127 for 60 min at room temperature in physiological
saline solution (PSS, containing in mmol/L, NaCl 135, KCl 5, CaCl2 1.8,
MgCl2 1, D-glucose 11, and HEPES 10, pH 7.4) and then washed three
times with PSS to remove extracellular fura 2-AM. Individual cells were
defined as the region of interest and average fluorescence was measured
using the PTI Fluorescence Master Systems (Photon Technology Inter-
national, NJ, USA).
Fluorescence was measured at 510 nm with excitation wavelengths of
340 and 380 nm. Images and F340 nm/F380 nm ratio were acquired and
analysed using the Felix32 Software.
2.5 Statistics
All values reported are mean+ SEM. Comparisons between groups were
analysed using Student’s t-test or one-way ANOVA with Bonferroni’s mul-
tiple comparison post hoc test as appropriate (Graph Pad Prism; LaJolla
CA, USA). A two-sided P-value of ,0.05 was considered to indicate stat-
istical significance.
3. Results
3.1 Expression and function of TRPV1 in
VSMC and aorta
TRPV1 mRNA (Figure 1A) and protein expression (Figure 1B) could be
detected in aortic tissue and cultured VSMC from wild-type mice but
not from TRPV12/2 mice. A positive control was obtained from the
brain tissue of wild-type mice. However, neither TRPV1 mRNA nor
TRPV1 protein was detected in a mouse macrophage cell line,
RAW264.7 (Figure 1A and B). Using immunohistochemistry, we con-
firmed that the presence of TRPV1 in the muscle layer of the aorta
removed the endothelium and adventitia from C57BL/6J mice
(Figure 1C). We also proved the presence of TRPV1 in VSMC
(Figure 1D). The specific TRPV1 agonist, capsaicin (1 mmol/L), signifi-
cantly increased the TRPV1 protein expression in VSMC (Figure 1E).
The specific TRPV1 agonists, capsaicin (Figure 1F and G) and resinifer-
atoxin (RTX; see Supplementary material online, Figure S1A and B),
dose-dependently increased cytosolic calcium concentrations in
VSMC from C57BL/6J mice. Furthermore, capsaicin-induced calcium
increase was significantly blocked in VSMC from TRPV12/2 mice or
in the presence of the antagonist capsazepine (1 mmol/L) and
5′-indo-RTX (1 mmol/L) (Figure 1H and I ). These results indicated
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Figure 1 Expression and function of TRPV1 on calcium influx in VSMC. (A) RT–PCR showing the expression of TRPV1 mRNA in the brain, aorta,
and primarily cultured VSMC from C57BL/6J wild-type mice but not in those from TRPV12/2 mice and in a mouse macrophage cell line, RAW264.7.
Predicted product size was 435 bp. (B) Immunoblotting showing TRPV1 protein expression in the brain, aorta, and VSMC from C57BL/6J wild-type
mice, but not in those from TRPV12/2 mice and in RAW264.7. (C and D) Immunohistochemistry showing TRPV1 in the aorta (C) and VSMC (D) from
C57BL/6J mice. Scale bar ¼ 50 mm. (E) Effect of TRPV1 agonist capsaicin (Caps) on TRPV1 protein expression, VSMC were stimulated with 1 mmol/L
Caps for 24 h and TRPV1 protein were analysed. Each n ¼ 6; *P, 0.05. (F and G) Dose-dependent capsaicin induced calcium influx into VSMC from
C57BL/6J mice. Representative fluorescence tracings (F) and summary of the data (G) are shown. Each n ¼ 4–6; *P, 0.05; **P, 0.01. (H and I ) Caps
(1 mmol/L) induced calcium influx into VSMC from C57BL/6J mice (Control), but not in VSMC from TRPV12/2 mice or after pre-treatment with
capsazepine (1 mmol/L, Capz) or 5′-iodo-RTX (1 mmol/L) for 10 min. Representative fluorescence tracings (H ) and summary of the data (I ) are
shown. Each n ¼ 4–6; *P, 0.05; **P, 0.01.
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the presence and functional integrity of TRPV1 channels in VSMC,
extending the observations in recent literature.13
3.2 Activation of TRPV1 by capsaicin
reduces accumulation of lipids in VSMC
There is indirect evidence linking TRPV1 with lipid storage and lipid
metabolism.10,14 Therefore, we investigated the effects of TRPV1 acti-
vation on lipid accumulation in VSMC. Oil red O staining of intracellular
lipid droplets showed that the administration of 50 mg/mL oxidized LDL
(oxLDL) for 72 h significantly increased lipid accumulation in cultured
VSMC from C57BL/6J mice by about 154+13% from n ¼ 6 separate
experiments (Figure 2A). As indicated in Figure 2B, the administration
of the TRPV1 agonist capsaicin (1 mmol/L) significantly reduced intra-
cellular lipid droplets in oxLDL-stimulated VSMC from C57BL/6J
mice but not TRPV12/2 mice. The inhibition of capsaicin on intracellu-
lar lipid droplets was reversed by TRPV1 antagonist capsazepine in a
concentration-dependent manner (see Supplementary material
online, Figure S2). The total cholesterol level of VSMC from C57BL/6J
mice was significantly reduced by capsaicin (control, 0.31+ 0.05 mg/
106 cells; capsaicin, 0.17+ 0.02 mg/106 cells; each n ¼ 5–6, P, 0.05
by ANOVA; Figure 2C), which was more pronounced when VSMC
were cultured in the presence of 50mg/mL oxLDL (Figure 2D).
3.3 Activation of TRPV1 affects
cholesterol transporters in VSMC
After we identified the regulatory effect of TRPV1 on total cellular
cholesterol level, we investigated whether TRPV1 activation may
directly affect cholesterol transporters that are associated with intra-
cellular cholesterol accumulation. First, we showed that both ABCA1
and LRP1 are colocalized with TRPV1 on VSMC (Figure 3A and B). Fur-
thermore, oil red O staining of intracellular lipid droplets showed that
RNA interference knockdown of ABCA1 reversed capsaicin-induced
reduction in lipid accumulation in cultured VSMC from C57BL/6J
mice (see Supplementary material online, Figure S3A), and RNA interfer-
ence knockdown of LRP1 had the synergistic effect with capsaicin in
attenuated lipid accumulation in VSMC (see Supplementary material
Figure 2 Activation of TRPV1 reduces accumulation of lipids in VSMC. (A) Representative pictures of oil red O staining of intracellular lipid droplets
in cultured VSMC from C57BL/6J mice without (Control) and with administration of 50 mg/mL oxLDL for 72 h. Scale bar ¼ 10 mm. (B) Oil red O
staining of intracellular lipid droplets in oxLDL-stimulated VSMC from C57BL/6J mice or from TRPV12/2mice in the absence (Control) and presence
of Caps or Capz. VSMC were cultured in the presence of 50 mg/mL oxLDL for 3 days when images of intracellular lipid droplets were obtained.
Representative pictures of three independent experiments are shown. Scale bar ¼ 50 mm. (C and D) Bar graphs showing total cholesterol levels
in VSMC from C57BL/6J and TRPV12/2 mice under routine culturing conditions (C) and after culturing in the presence of 50 mg/mL oxLDL for 3
days (D). Total intracellular cholesterol was measured in VSMC from C57BL/6J and TRPV12/2 mice cultured in the absence (Control) or presence
of Caps or Capz. Data are mean+ SEM from five to six independent experiments. *P, 0.05 compared with Control.
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online, Figure S3B). The activation of TRPV1 by the specific agonist cap-
saicin significantly increased the expression of ABCA1 from 1.00+0.06
to 2.18+0.20 (n ¼ 3, P, 0.05; Figure 3C), whereas it significantly
reduced the expression of LRP1 from 1.00+ 0.20 to 0.53+ 0.08
(n ¼ 6, P, 0.05; Figure 3D). However, these effects of capsaicin disap-
peared in VSMC from TRPV12/2 mice (Figure 3C and D).
3.4 TRPV1 activation regulates ABCA1/
LRP1 expression by calcium-evoked
calcineurin- and PKA-dependent
mechanisms in VSMC
For further understanding of the possible molecular mechanisms of
ABCA1 and LRP1 expression regulated by TRPV1 activation, we
detected the role of PKA and calcineurin in the expression of
ABCA1 and LRP1 stimulated by capsaicin. Cyclosporin A (CsA), a
specific inhibitor of calcineurin, had an inhibitory tendency on
capsaicin-activated ABCA1 expression (Figure 4A), and blocked the
effects of TRPV1 activation on LRP1 expression (0.57+ 0.06
vs.1.02+ 0.08; n ¼ 3, P, 0.05; Figure 4B). As shown in Supplemen-
tary material online, Figure S4, capsaicin increased the expression of
phospho-PKA. KT5720, a specific inhibitor of PKA, blocked the
effects of TRPV1 activation on ABCA1 (1.35+ 0.06 vs.0.83+0.07;
n ¼ 3, P, 0.01; Figure 4C) and LRP1 expression (0.34+ 0.05
vs.0.71+ 0.10; n ¼ 3, P, 0.05; Figure 4C). As expected, trapping of
intracellular calcium by BAPTA blocked the effects of capsaicin on
ABCA1 and LRP1 expression (Figure 4D). However, peroxisome pro-
liferator activated receptor gamma (PPARg) antagonist, GW9662, did
not affect ABCA1 expression after activation of TRPV1 (see Sup-
plementary material online, Figure S5). These results in vitro indicated
that TRPV1 activation increased ABCA1 expression and reduced
LRP1 expression, leading to increased cholesterol efflux and
reduced cholesterol uptake of VSMC, through calcium-dependent cal-
cineurin signal and PKA phosphorylation mechanisms.
Figure 3 Activation of TRPV1 affects cholesterol transporters ABCA1 and LRP1 in VSMC. (A and B) Immunofluorescence showing the colocaliza-
tion of ABCA1 (A) and LRP1 (B) with TRPV1 on the surface of VSMC from C57BL/6J mice. ABCA1, LRP1, and TRPV1 were identified using specific
primary antibodies and fluorescence-labelled secondary antibodies. 4,6-Diamidino-2-phenylindol (DAPI) was used for nuclear counterstaining (blue
fluorescence). Negative controls (Control) were performed with phosphate-buffered saline (PBS) instead of primary antibodies. Scale
bar ¼ 50 mm. (C and D) Representative immunoblottings and summary data showing the effect of capsaicin on the expression of ABCA1 (C) and
LRP1 (D) in VSMC from C57BL/6J wild-type mice and TRPV12/2 mice. VSMC were cultured in the absence (Control) or presence of 1 mmol/L
Caps for 24 h. Data are mean+ SEM, each n ¼ 3–6; *P, 0.05.
L. Ma et al.508
by guest on January 16, 2017
D
ow
nloaded from
 
3.5 In vivo activation of TRPV1 increases
ABCA1 expression and reduces LRP1
expression in aorta from ApoE2/2 mice
To confirm these effects in vivo, we evaluated the effects of TRPV1
activation on cholesterol transporters in ApoE2/2 mice. Table 1
showed the characteristics of ApoE2/2 mice that were randomly allo-
cated to a normal diet, a high-fat diet, normal diet plus capsaicin, or a
high-fat diet plus capsaicin, respectively. Compared with mice on
normal diet, administration of a high-fat diet significantly increased
plasma triglycerides by 300% and total cholesterol by 72% in
ApoE2/2 mice (P, 0.01; Table 1). Compared with mice on a
high-fat diet, the mice on a high-fat diet plus capsaicin showed signifi-
cantly lower plasma triglycerides (2.39+0.50 vs. 4.17+0.74 mmol/L,
P , 0.05 Table 1) and significantly lower total cholesterol (13.75+
2.17 vs. 18.62+ 1.54 mmol/L, P, 0.05; Table 1). In ApoE2/2 mice
on a high-fat diet, capsaicin did not affect fasting plasma glucose or
insulin (Table 1). No difference in plasma lipids was shown in
ApoE2/2TRPV12/2 mice fed with different diets (see Supplementary
material online, Figure S6). Using immunofluorescence, we confirmed
the expression of TRPV1, ABCA1, and LRP1 in the aorta from
ApoE2/2 mice (Figure 5A and B). Compared with ApoE2/2 mice on
a high-fat diet, the ApoE2/2 mice on a high-fat diet plus capsaicin
showed significantly higher expression of ABCA1 in the aorta
(5.60+1.62 vs. 1.32+1.21, n ¼ 3, P, 0.05; Figure 5C) and
reduced expression of LRP1 in the aorta (0.55+0.04 vs. 0.81+
0.04; n ¼ 3, P, 0.05; Figure 5D), and similar changes of ABCA1 and
LRP1 in the aorta between ApoE2/2 mice on normal diet and
Figure 4 TRPV1 activation regulates ABCA1/LRP1 expression by calcium evoked calcineurin- and PKA-dependent mechanisms. (A and B) Repre-
sentative immunoblottings and summary data showing the effect of the calcineurin inhibitor CsA on the expression of ABCA1 (A) and LRP1 (B) in
VSMC from C57BL/6J wild-type mice. VSMC were treated without (Control) or with 1 mmol/L Caps for 24 h in the presence of 1 mmol/L CsA
(Caps + CsA). Data are mean+ SEM, each n ¼ 3–5; *P, 0.05; **P, 0.01. (C) Representative immunoblottings and summary data showing the
effect of PKA inhibitor KT5720 (10 mmol/L) on the expression of ABCA1 and LRP1 in VSMC from C57BL/6J wild-type mice. VSMC were cultured
in the absence (Control) or presence of 1 mmol/L Caps for 24 h without or with KT5720. Data are mean+ SEM, each n ¼ 3–6; *P, 0.05;
**P, 0.01. (D) Representative immunoblottings and summary data showing the effect of BAPTA (10 mmol/L) on the expression of ABCA1 and
LRP1 in VSMC from C57BL/6J mice. VSMC were cultured in the presence of BAPTA (10 mmol/L) for 2 h. Data are mean+ SEM, each n ¼ 3.
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Table 1 Biochemical characteristics of ApoE2/2 mice after 24 weeks of treatment
ND (n5 20) NCaps (n5 15) HD (n 5 16) HCaps (n 5 16)
Total cholesterol (mmol/L) 10.81+0.58 7.57+0.56 18.62+1.54** 13.75+2.17#,&&
Triglyceride (mmol/L) 1.04+0.08 0.66+0.06 4.17+0.74** 2.39+0.50#,&&
HDL-C (mmol/L) 1.69+0.31 1.53+0.02 2.19+0.40 2.56+0.38
LDL-C (mmol/L) 1.72+0.22 1.11+0.06 2.22+0.37 2.15+0.20&&
Insulin (IU/L) 13.24+1.99 10.62+1.33 12.14+0.96 13.82+2.64
Glucose (mmol/L) 7.41+0.74 7.45+0.77 6.41+0.58 7.51+0.83
ND, normal diet; NCaps, normal diet plus capsaicin; HD, high-fat diet; HCaps, high-fat diet plus capsaicin; HDL-C, high-density lipoprotein-cholesterol; LDL-C, low-density
lipoprotein-cholesterol. Values are expressed as mean+ SEM for 15–20 animals.
**P, 0.01 vs. ND group.
#P, 0.05 vs. HD group.
&&P, 0.05 vs. NCaps group.
Figure 5 In vivo activation of TRPV1 affects cholesterol transporters in the aorta. ApoE2/2 mice were randomly allocated to four groups, which
were fed for 24 weeks with normal diet (ND), normal diet plus capsaicin (NCaps), high-fat diet (HD), or high-fat diet plus capsaicin (HCaps), respect-
ively. (A and B) Immunofluorescence showing the colocalization of ABCA1 (A) and LRP1 (B) with TRPV1 on the surface of the aorta from C57BL/6J
mice. ABCA1, LRP1, and TRPV1 were identified using specific primary antibodies and fluorescence-labelled secondary antibodies. Negative controls
(Control) were performed with PBS instead of primary antibodies. Scale bar ¼ 200 mm. (C and D) Representative immunoblottings and summary data
showing the in vivo effect of capsaicin on the expression of ABCA1 (C) and LRP1 (D) in the aorta from ApoE2/2 mice. Data are mean+ SEM of aortas
from ApoE2/2 mice randomly allocated to ND, NCaps, HD, or HCaps for 24 weeks, respectively. Each n ¼ 3; *P, 0.05 by ANOVA.
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ApoE2/2 mice on normal diet plus capsaicin were also observed
(Figure 5C and D). On the other hand, long-term administration of
capsaicin did not affect the expressions of other cholesterol transpor-
ters and receptors, such as scavenger receptor type A (SR-A), ATP-
binding cassette subfamily G member 1 (ABCG1), lectin-like oxidized
low-density lipoprotein receptor-1 (LOX-1), and caveolin-1 (Cav-1)
in ApoE2/2 mice (see Supplementary material online, Figures S7
and S8).
3.6 TRPV1 reduces lipid storage and
atherosclerotic lesions in ApoE2/2 but not
ApoE2/2TRPV12/2 mice on a high-fat diet
To prove that TRPV1 directly affects atherosclerosis, we compared
the effects of chronic activation of TRPV1 on atherosclerotic
lesions from ApoE2/2 and ApoE2/2TRPV12/2 mice. PCR was
used to identify the ApoE genotype (Figure 6A) and TRPV1 genotype
(Figure 6B). Food intake showed differences between mice fed with
and without capsaicin only during the first 4 days, then mice fed
with capsaicin recovered to normal eating (Figure 6C and D). As
shown in Supplementary material online, Figure S9A and Figure 6E,
lipid storage in atherosclerotic lesions of the descending thoracoab-
dominal aorta was significantly lower in ApoE2/2 mice on a high-fat
diet plus capsaicin compared with ApoE2/2 mice on a high-fat diet
(0.52+0.27 vs. 1.00+0.29; n ¼ 6, P, 0.05). Furthermore,
ApoE2/2TRPV12/2 mice on a high-fat diet plus capsaicin had
similar atherosclerotic lesions compared with ApoE2/2TRPV12/2
mice on a high-fat diet (0.99+0.06 vs. 1.00+0.13; n ¼ 6, P ¼ NS).
Similar findings were obtained in histomorphological analyses of
atherosclerotic lesions in the aortic sinus. The lesions in the aortic
sinus was significantly decreased in ApoE2/2 mice on a high-fat diet
plus capsaicin compared with ApoE2/2 mice on a high-fat diet
Figure 6 In vivo activation of TRPV1 reduces atherosclerotic lesions in the aorta in ApoE2/2 mice but not in ApoE2/2TRPV12/2 mice on a high-fat
diet. Genotyping of F2 mice to verify the APOE2/2TRPV12/2 mice by PCR. The predicted products are 245 bp (A) and 600 bp (B). (C and D) Bar
graphs showing daily food intake during the first 10 days after the start of treatment in ApoE2/2 mice (C) and ApoE2/2TRPV12/2 mice (D). Mice
were randomly allocated to groups, which were fed for 24 weeks with normal diet (ND), normal diet plus capsaicin (NCaps), high-fat diet (HD), or
high-fat diet plus capsaicin (HCaps), respectively. (E) Summary data of computer-assisted quantitative image analysis of lipid deposition in the descend-
ing thoracoabdominal aorta of ApoE2/2 mice and ApoE2/2TRPV12/2 mice. Each n ¼ 6; **P, 0.01. (F) Bar graphs showing atherosclerotic lesions in
aortic sinus of consecutive sections of the haematoxylin–eosin-stained aortic root quantified by computer-assisted image analysis. Data are
mean+ SEM. Each n ¼ 5–10; **P, 0.01.
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(0.52+0.09 vs. 1.00+0.19; n ¼ 8–10, P, 0.05; see Supplementary
material online, Figure S9B and Figure 6F). There were no significant
differences in lesions in ApoE2/2TRPV12/2 mice on a high-fat diet
plus capsaicin compared with ApoE2/2TRPV12/2 mice on a
high-fat diet (see Supplementary material online, Figure S9B and
Figure 6F). Moreover, immunohistochemical analysis and sirius red
staining of atherosclerotic lesions in the aortic sinus showed that no
significant differences were observed in the composition of athero-
sclerotic lesions in all ApoE2/2 mice groups (see Supplementary
material online, Figure S10). These results confirmed our experimental
evidence that long-term activation of TRPV1 ameliorates
high-fat-induced atherosclerosis.
4. Discussion
Accumulation of vascular lipids is one major event in the pathogenesis
of atherosclerosis. ABCA1 is a protein that mediates the cellular efflux
of phospholipids and cholesterol to lipid-poor apolipoprotein A1,15
and LRP1 is an a-2-macroglobulin receptor on the cell surface that
enhances the cholesterol influx.16 Here, we give experimental evi-
dence that activation of TRPV1 reduces accumulation of lipids in cul-
tured cells by increased cholesterol efflux due to increased ABCA1
expression and reduced lipid uptake due to reduced LRP1 expression.
In vivo too, the administration of the TRPV1 agonist capsaicin
increased ABCA1 expression, reduced LRP1 expression, and finally
reduced lipid storage and atherosclerotic lesions in ApoE2/2 mice
but not in the aorta from ApoE2/2TRPV12/2 mice. The results of
our present study reveal a key contribution of TRPV1 for the preven-
tion of atherosclerosis in mice on a high-fat diet.
Although macrophage-foam cell formation in atherosclerotic
lesions has been extensively studied, little is known on how VSMC
become foam cells by regulating cholesterol transporter. VSMC
have a variety of cholesterol uptake receptors and reverse cholesterol
transporters, including the LDL receptor, LRP1, and the ABCA1.2,4,17
LRP1 is highly expressed in the vascular wall and LRP1-mediated,
matrix-retained LDL internalization could be crucial for the formation
of VSMC-derived foam cell.16 Recently, Judith et al. showed that Ang II
upregulates LRP1 receptor expression and LRP1-mediated aggregated
LDL uptake in vascular cells.3 With continued lipid loading in a
proatherogenic milieu, VSMC go on to downregulate the levels of
ABCA1, enhancing foam cell formation.4,15 These studies suggest
that lipid accumulation in VSMC may contribute to atherosclerosis
development. However, the mechanism of lipid accumulation and its
uptake by VSMC was poorly investigated.
It has been well known that TRPV1 channels were expressed in
sensory nerves mediating the action of heat, acid, or pain.8 Activation
of TRPV1 by capsaicin mediates a painful, burning sensation in the
human gut via TRPV1. Acute exposure to capsaicin or chili aggravates
abdominal pain in patients with dyspepsia and irritable bowel syn-
drome. However, chronic ingestion of chili was found to improve
functional dyspepsia and gastro-oesophageal reflux disease symptoms
in small randomized, controlled studies.18 According to literatures,
some effects of capsaicin on carbohydrate metabolism have been
reported. Dietary capsaicin may reduce fasting glucose, insulin
levels, and affect glucose tolerance in obese mice.19 On the other
hand, capsaicin may increase both glucose absorption from the gastro-
intestinal tract and the release of glucagon.20 However, in the present
study, glucose and insulin levels were not significantly different
between ApoE2/2 mice fed with and without capsaicin. TRPV1
channels have also been demonstrated in vascular system, including
endothelial cells and VSMC.7,21 Currently, it is unknown whether
TRPV1 channels are uniformly distributed in all cell types from differ-
ent blood vessels, including the aorta, coronary arteries, or mesen-
teric arteries. Chronic activation of TRPV1 improves
endothelium-dependent vasodilatation through increasing PKA and
eNOS phosphorylation.9 Tissue-specific activation of TRPV1 channels
may mediate endothelium-dependent vasodilatation or smooth-
muscle-associated vasoconstriction.22,23 In the present study, we
not only confirmed the expression of TRPV1 mRNA and protein in
VSMC and aorta, but also confirmed the expected molecular mass
of TRPV1 of 95 kDa and showed that the antibodies were able to
identify TRPV1 by immunoblots.
The capsaicin-induced calcium influx through TRPV1 channels has
already been reported in HEK293 cells transfected with encoding
cDNA of TRPV1.8 Moreover, capsaicin, as a known specific agonist of
TRPV1 channels, induced a dose-dependent calcium influx into
VSMC.24 As reported, TRPV1 activity is involved in calcineurin
pathway.25 A similar mechanism of calcineurin–nuclear factor-activated
T cells (NFAT)-dependent activation of TRPC3 and TRPC6 gene
expression has also recently reported in myocardial cells.26,27 Similar
to those reports, we showed that specific activation of TRPV1 by cap-
saicin could not only cause transmembrane calcium influx and increase
the expression of TRPV1, but also reduce the accumulation of lipids in
VSMC. Which mechanisms mediate the reduced intracellular lipid
accumulation after TRPV1 activation? Previous reports showed that
elevated cytosolic calcium markedly suppressed intracellular lipid
accumulation and cholesterol and triglyceride levels in adipocytes.28,29
Similar to that, we showed that capsaicin-induced elevation of cytosolic
calcium enhanced cholesterol efflux and reduced cholesterol influx
through increasing ABCA1 expression and decreasing LRP1 expression
in cultured VSMC, as a result, reduced intracellular lipid droplets and
cholesterol levels in VSMC, as well as in the aorta from ApoE2/2
mice on a high-fat diet. However, the regulation effects of capsaicin
were not observed on other cholesterol transporters and receptors,
such as SR-A, ABCG1, LOX-1, and Cav-1 in the aorta, although they
were also considered playing roles in intracellular lipid homeostasis in
the procedure of atherogenesis.30–33 In recent literature, cholesterol-
lowering intervention by simvastatin downregulated the overexpres-
sion of vascular LRP1 induced by hypercholesterolaemia and that sim-
vastatin did not influence LRP1 expression beyond its
cholesterol-lowering effects in male New Zealand rabbits.34 According
to our present data, in vivo in mice and in cultured cells, the observed
effects of capsaicin are primarily caused by its activation of TRPV1 chan-
nels, rather than indirectly by lowering hypercholesterolaemia, although
we observed lower plasma triglycerides and total cholesterol after
administration of capsaicin in vivo. It cannot be excluded that several
TRPV1-associated mechanisms collaborate in vivo. In vivo, both the
TRPV1-associated reduction in plasma cholesterol including the
reduction in remnant lipoprotein particles and the TRPV1-associated
increase in ABCA1 expression and reduction in LRP1 expression in
VSMC will result in prevention of atherosclerosis.
The underlying mechanisms of calcium-dependent regulation of
cholesterol transporter are supported by previous studies. PPARg
enhances cholesterol efflux by inducing the transcription of
liver-X-receptor a and thus inducing ABCA1 expression.35 Inhibiting
calcineurin by special immunosuppressant sirolimus with CsA was
reported to downregulate ABCA1 protein expressions.36 Kiss
et al.37 and Zhu and Hui38 showed that ABCA1 and LRP1 were
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regulated by PKA, which is calcium-dependent. Taken together, we
supposed that increased cytosolic calcium will modulate PPARg-,
calcineurin-, and PKA-dependent pathways, thus will finally change
cholesterol transporters expression. However, our experimental
data using PPARg antagonist showed that the increased ABCA1
expression after activation of TRPV1 may not be explained by
PPARg mechanism. Moreover, our research elucidated that TRPV1
activation increased ABCA1 expression and reduced LRP1 expression
through calcineurin- and PKA-dependent mechanisms, which were
calcium-evoked, thus leading to increased cholesterol efflux and
reduced cholesterol uptake into VSMC. The capsaicin content was
found to range from 2.19 to 19.73 mg/g of dry weight of capsicum
fruits.39 Moreover, one human study showed that regular consump-
tion of chili (30 g/day; 55% cayenne chili) for 4 weeks may attenuate
postprandial hyperinsulinaemia.40 Based on these values, one may esti-
mate that average 18 g dried chili (about 180 mg capsaicin) per day
would be beneficial to humans.
In summary, our present study for the first time gives experimental
evidence that continuous activation of TRPV1 seems to be a promis-
ing novel mechanism to attenuate atherosclerosis evoked by a
high-fat diet.
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Supplementary material is available at Cardiovascular Research online.
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